Smart Inhalers Market
Smart Inhalers Market Size, Share, Growth and COVID19 Impact Analysis. Forecast years covered from 2026 to 2030
Explore reportThe Radiation Therapy-based Glioblastoma Multiforme Treatment Market was valued at USD 3.72 billion in 2024 and is projected to reach a market size of USD 6.13 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 8.68%.
Radiation therapy is the primary treatment for GBM due to the tumor’s aggressive nature and limited surgical options. Advanced techniques like IMRT, SRS, and proton therapy allow precise targeting of tumor cells while sparing healthy tissue, enhancing patient survival and recovery.
North America, driven by advanced healthcare infrastructure and technology adoption, is the largest market. Asia-Pacific is the fastest-growing region due to increasing cancer incidence, healthcare investments, and the rapid adoption of advanced radiation technologies in countries like China, India, and Japan.
The market is witnessing innovations such as AI-driven treatment planning, personalized radiotherapy, CAR-T cell therapies, FLASH radiotherapy, and Tumor Treating Fields (TTFields). These developments improve precision, efficiency, and patient outcomes while enabling combination treatments with immunotherapy and targeted therapies.
Key market players include Merck & Co., Amgen, F. Hoffmann-La Roche, Pfizer, Teva, Sun Pharmaceutical Industries, Varian Medical Systems, Elekta AB, Bayer, and Arbor Pharmaceuticals. These companies are actively involved in developing advanced radiation technologies, targeted therapies, and collaborative clinical trials.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.